GlassScriptPhysician profile
Lisa Waterman
NPI 1467455808
$15,798.82
in general payments reported to CMS, 2019-2025
13 companies · $1,032 in 2025
The $1,032 reported for 2025 was more than what 91% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $298 · 2020: $14.09 · 2021: $167 · 2022: $871 · 2023: $104 · 2024: $13K · 2025: $1,032.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $12K · Food and Beverage: $1,369 · Travel and Lodging: $1,079.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $12,000.00 |
| Food and Beverage | $1,368.91 |
| Travel and Lodging | $1,079.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $14,741.65 | 2022-2025 | Da Vinci Surgical System |
| Abbvie INC. | $501.83 | 2019-2023 | Liletta |
| Organon LLC | $157.27 | 2023-2025 | Nexplanon |
| Merck Sharp & Dohme LLC | $77.16 | 2019 | |
| Hologic Sales and Service, LLC | $67.01 | 2024-2025 | Thinprep 2000 Processor, Aptima |
| Caldera Medical, INC | $46.74 | 2025 | |
| Allergan, INC. | $41.19 | 2019-2020 | |
| Astellas Pharma US INC | $37.45 | 2021-2024 | Veozah |
| Boston Scientific Corporation | $37.04 | 2025 | Solyx Sis System |
| Minerva Surgical, INC | $32.98 | 2024 | |
| Biogen, INC. | $26.36 | 2024 | Zurzuvae |
| Sage Therapeutics, LLC | $17.70 | 2024 | |
| Amag Pharmaceuticals, INC. | $14.44 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Waterman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.